# | Title | Journal | Year | Citations |
---|
1 | FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 1,147 |
2 | Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy | Journal of Nuclear Medicine | 2015 | 907 |
3 | Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer | Journal of Urology | 2016 | 659 |
4 | Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain—an fMRI analysis | Pain | 2004 | 592 |
5 | Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 510 |
6 | Prevalence of Amyloid PET Positivity in Dementia Syndromes | JAMA - Journal of the American Medical Association | 2015 | 501 |
7 | Current use of PSMA–PET in prostate cancer management | Nature Reviews Urology | 2016 | 469 |
8 | First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses | Journal of Nuclear Medicine | 2012 | 466 |
9 | Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer | European Urology | 2016 | 456 |
10 | Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment | Journal of Clinical Oncology | 2004 | 448 |
11 | Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography | Cancer Research | 2001 | 446 |
12 | 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies | Journal of Nuclear Medicine | 2015 | 432 |
13 | Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study | Lancet Neurology, The | 2018 | 383 |
14 | The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 355 |
15 | O -(2-[ 18 F]Fluoroethyl)- l -tyrosine and l -[methyl- 11 C]methionine uptake in brain tumours: initial results of a comparative study | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 353 |
16 | Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy | International Journal of Radiation Oncology Biology Physics | 2005 | 351 |
17 | Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis | Journal of Nuclear Medicine | 2001 | 351 |
18 | Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man | Clinical Cancer Research | 2006 | 337 |
19 | Exploring the Role of RGD-Recognizing Integrins in Cancer | Cancers | 2017 | 308 |
20 | Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2016 | 302 |
21 | [18F]Galacto-RGD: Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose Estimates | Bioconjugate Chemistry | 2004 | 299 |
22 | FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 290 |
23 | SPECT/CT | Journal of Nuclear Medicine | 2008 | 280 |
24 | Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting | Journal of Nuclear Medicine | 1999 | 265 |
25 | Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy | Journal of Nuclear Medicine | 2019 | 238 |
26 | Hypoxia Imaging With FAZA-PET and Theoretical Considerations With Regard to Dose Painting for Individualization of Radiotherapy in Patients With Head and Neck Cancer | International Journal of Radiation Oncology Biology Physics | 2007 | 226 |
27 | 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning | Journal of Nuclear Medicine | 2018 | 226 |
28 | Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. | Journal of Clinical Oncology | 1996 | 223 |
29 | An Interindividual Comparison of O-(2- [18F]Fluoroethyl)-L-Tyrosine (FET)– and L-[Methyl-11C]Methionine (MET)–PET in Patients With Brain Gliomas and Metastases | International Journal of Radiation Oncology Biology Physics | 2011 | 222 |
30 | [18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck | Clinical Cancer Research | 2007 | 217 |
31 | Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy | Journal of Nuclear Medicine | 2016 | 213 |
32 | Imaging of integrin αvβ3 expression | Cancer and Metastasis Reviews | 2008 | 208 |
33 | Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer | European Urology | 2019 | 206 |
34 | Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose | Journal of the National Cancer Institute | 1996 | 205 |
35 | Radiolabelled RGD peptides for imaging and therapy | European Journal of Nuclear Medicine and Molecular Imaging | 2012 | 203 |
36 | Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients | Journal of Nuclear Medicine | 2005 | 202 |
37 | Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study | Neurobiology of Aging | 2004 | 201 |
38 | PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18 F-labelled, carbohydrated analogue of octreotide | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 197 |
39 | 99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer | European Urology | 2019 | 195 |
40 | Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study | Neurobiology of Aging | 2007 | 194 |
41 | Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer | European Urology | 2015 | 192 |
42 | E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 188 |
43 | In vivo molecular imaging of chemokine receptor CXCR 4 expression in patients with advanced multiple myeloma | EMBO Molecular Medicine | 2015 | 180 |
44 | The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer | European Urology | 2011 | 177 |
45 | MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients | European Radiology | 2008 | 176 |
46 | Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas | Journal of Nuclear Medicine | 1995 | 176 |
47 | Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG | Journal of Nuclear Medicine | 2008 | 173 |
48 | CXCR4 Expression Increases Liver and Lung Metastasis in a Mouse Model of Pancreatic Cancer | Gastroenterology | 2005 | 172 |
49 | Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine | Journal of Nuclear Medicine | 2019 | 172 |
50 | An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging | Journal of Nuclear Medicine | 2014 | 171 |